Audited Results of Corona Remedies Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024
Operating Income	1,403.18	1,196.42	1,014.47
Manufacturing Expenses	5.69	6.03	5.66
Personnel Expenses	403.02	346.14	295.37
Selling Expenses	0	0	0
Administrative Expenses	440.09	367.75	331.89
Expenses Capitalised	0	0	0
Cost Of Sales	1,109.74	956.44	859.74
Operating Profit	293.44	239.98	154.74
Other Recurring Income	10.65	5.94	6.46
Adjusted PBDIT	304.09	245.91	161.19
Financial Expenses	6.97	10.60	14.44
Depreciation	37.87	37.16	28.28
Other Write offs	0	0	0
Adjusted PBT	259.25	198.15	118.48
Tax Charges	55.30	49.10	27.98
Adjusted PAT	203.95	149.05	90.50
Non Recurring Items	-18.99	-0.87	-1.67
Other Non Cash adjustments	0	0	0
Reported Net Profit	184.85	149.05	90.50
Equity Dividend	44.71	22.63	16.94
Preference Dividend	0	0	0
Retained Earnings	643.23	502.98	377.43

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article